UNDERSTANDING ANAPLASTIC LARGE-CELL LYMPHOMA (ALCL): TYPES, CAUSES, AND TREATMENT Anaplastic Large-Cell Lymphoma (ALCL) is a rare and aggressive form of non-Hodgkin lymphoma that primarily impacts ...

The majority of patients with large B cell lymphomas fail to respond to CAR-T-cell therapy, but ‘warming up’ or ‘cooling down’ the microenvironment may help improve outcomes. CD19-targeted chimeric ...

To confirm a diagnosis and determine the stage of the disease, your doctor will use a series of tests: Biopsy: This is the most definitive test. A surgeon will remove all or part of an affected lymph ...

In a breakthrough cancer therapy development, scientists at MIT and Harvard Medical School created a new way of designing ...

Our immune systems have the thankless jobs of guarding us from bacterial and viral invaders and preventing cancer development. Most of the time, we do not notice this hard work because the invaders ...

The National Institute for Health and Care Excellence (NICE) has approved a chimeric antigen receptor (CAR) T-cell therapy for adults with large B-cell lymphoma. The treatment significantly delays ...

T cell therapy, which uses a patient's own immune cells to fight cancer, has emerged as a powerful way to treat lymphoma and ...

A phase I study of a next-generation CAR T cell therapy showed a 52 percent complete remission rate for patients with relapsed/refractory lymphoma. A next-generation "armored" CAR T cell therapy ...

MIT and Harvard scientists have created engineered CAR-NK cells that can hide from the immune system and more effectively ...

One of the newest weapons that scientists have developed against cancer is a type of engineered immune cell known as CAR-NK ...